MOUNTAIN VIEW, Calif., April 13 /PRNewswire/ -- Aviron (Nasdaq: AVIR),
today announced that it has sold 144,185 shares of its common stock,
registered under its Registration Statement on Form S-3 (No. 333-87185), to
Acqua Wellington Asset Management LLC for an aggregate price of $4,000,000 or
$27.74 per share. The company did not pay any fees or other compensation in
connection with this transaction.
Net proceeds from the sale will be used to fund operating costs, capital
expenditures and working capital needs, which may include costs of FluMist(TM)
regulatory filings and the manufacturing and commercialization of FluMist(TM)
in its current formulation; development of a second-generation formulation of
FluMist(TM); research and development of other pipeline products; development
of the infrastructure necessary to support these activities; and other general
corporate purposes.
Aviron is a biopharmaceutical company based in Mountain View, California,
focused on the prevention of disease through innovative vaccine technology.
Actual results may differ materially from the forward-looking statements
contained in this release. Factors that could cause actual results to differ
include, but are not limited to, failure to validate the manufacturing
process, facilities or equipment for the company's nasal influenza vaccine,
and the assessment by regulatory agencies that the company's future license
applications for its nasal influenza vaccine are incomplete or inadequate to
approve the product for marketing to one or more target populations.
Additional information concerning factors that could cause such a difference
is contained in Aviron's SEC filings, including its S-3 Registration Statement
and Annual Report on Form 10-K for the year ended December 31, 1999.
To receive an index and copies of recent press releases, call Aviron's
News-On-Call toll-free fax service, 800-758-5804, extension 114000.
Additional information about the company can be found at
http://www.aviron.com.
SOURCE Aviron
 back to top
Related links:
http://www.aviron.com
Company News On-Call:
http://www.prnewswire.com/comp/114000.html or fax,
800-758-5804, ext. 114000
CONTACT:
John Bluth of Aviron, 650-919-3716; or
Claudette Hibbert of Fleishman-Hillard, 212-453-2000, for Aviron;
or Investors, John Bluth, 650-919-3716, or Fred Kurland,
650-919-6666, both of Aviron
|
